Methacholine Chloride Methapharm

Methacholine Chloride, the active ingredient in Methacholine Chloride Methapharm, is a muscarinic agonist presented as a solution for inhalation use. It induces bronchoconstriction to assess airway hyper‑responsiveness, primarily in patients undergoing bronchial challenge testing for asthma diagnosis.

GNH USA supplies Methacholine Chloride Methapharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methacholine Chloride is employed in bronchial challenge testing to evaluate airway hyper‑responsiveness in asthma and related research settings. - Asthma diagnosis: helps identify airway hyper‑responsiveness during methacholine challenge testing. - Research studies: used as a standardized agent to provoke bronchoconstriction in clinical research on respiratory function. - Occupational health screening: employed to assess susceptibility to bronchoconstrictive agents in workplace exposure evaluations.

Methacholine Chloride may cause a range of adverse reactions, most of which are related to its bronchoconstrictive action.

Common Side Effects: - Cough: transient irritation of the airway. - Throat irritation: mild discomfort during inhalation. - Shortness of breath: temporary increase in breathing difficulty. - Wheezing: mild bronchospasm. - Nasal congestion: mild nasal symptoms.

Serious or Rare Side Effects: - Severe bronchospasm: marked airway narrowing requiring medical intervention. - Hypotension: significant drop in blood pressure. - Anaphylactoid reaction: rare systemic allergic‑type response. - Pulmonary edema: rare accumulation of fluid in the lungs. - Cardiac arrhythmia: uncommon rhythm disturbances.

Prior to using Methacholine Chloride, clinicians should observe several safety measures. - Patient selection: assess baseline lung function before testing. - Pre‑medication review: discontinue bronchodilators as recommended prior to test. - Monitoring: continuous observation of respiratory status during and after inhalation. - Emergency equipment: ensure resuscitation equipment and bronchodilators are readily available. - Contraindications: avoid use in patients with recent myocardial infarction or uncontrolled hypertension. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Methacholine Chloride can interact with other medications that affect airway tone or cardiovascular function.

Major Interactions (Avoid): - Beta‑agonists: concurrent use may mask bronchoconstriction response. - Anticholinergics: may reduce test sensitivity by opposing muscarinic effects. - MAO inhibitors: potential for exaggerated cardiovascular responses.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may increase risk of cough during testing. - Theophylline: additive bronchoconstrictive effect possible. - Sedatives: may depress respiratory drive, complicating interpretation.